PHO.OL
Price:
$53
Market Cap:
$1.44B
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-05-30
Stock Exchange
OSL
Ticker
PHO.OL
According to Photocure ASA’s latest financial reports and current stock price. The company's current PE Ratio is 112.77. This represents a change of -925.95% compared to the average of -13.65 of the last 4 quarters.
The mean historical PE Ratio of Photocure ASA over the last ten years is 658.89. The current 112.77 PE Ratio has changed 1.61% with respect to the historical average. Over the past ten years (40 quarters), PHO.OL's PE Ratio was at its highest in in the September 2016 quarter at 3.91K. The PE Ratio was at its lowest in in the September 2019 quarter at -440.00.
Average
658.89
Median
-24.26
Minimum
-117.16
Maximum
6.84K
Discovering the peaks and valleys of Photocure ASA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.35%
Maximum Annual PE Ratio = 6.84K
Minimum Annual Increase = -17128.68%
Minimum Annual PE Ratio = -117.16
Year | PE Ratio | Change |
---|---|---|
2023 | 6.84K | -17128.68% |
2022 | -40.18 | -54.97% |
2021 | -89.23 | -23.84% |
2020 | -117.16 | -291.33% |
2019 | 61.23 | -319.94% |
2018 | -27.84 | 60.08% |
2017 | -17.39 | -168.00% |
2016 | 25.58 | -203.24% |
2015 | -24.77 | 4.37% |
2014 | -23.74 | 156.35% |
The current PE Ratio of Photocure ASA (PHO.OL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.24K
5-year avg
1.33K
10-year avg
658.89
Photocure ASA’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Photocure ASA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Photocure ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Photocure ASA's PE Ratio?
How is the PE Ratio calculated for Photocure ASA (PHO.OL)?
What is the highest PE Ratio for Photocure ASA (PHO.OL)?
What is the 3-year average PE Ratio for Photocure ASA (PHO.OL)?
What is the 5-year average PE Ratio for Photocure ASA (PHO.OL)?
How does the current PE Ratio for Photocure ASA (PHO.OL) compare to its historical average?